Mozart Therapeutics raises $55M to advance disease therapies
October 26, 2021 at 16:04 PM EDT
The Seattle company is developing treatments for celiac disease and inflammatory bowel disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|